Judge Tim Fox fined Johnson & Johnson and its subsidiary Janssen $1.1 billion today for nearly 240,000 violations of Arkansas’ Medicaid fraud law. Yesterday a jury found that the companies had hidden the risks of taking Risperdal. J&J will pay an additional $11 million for 4,500 violations of Arkansas’ deceptive practices act. The jury awarded its verdict after three hours of deliberation; Janssen indicated it will move for a new trial, and appeal if necessary.
Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.
Mad in America has made some changes to the commenting process. You no longer need to login or create an account on our site to comment. The only information needed is your name, email and comment text. Comments made with an account prior to this change will remain visible on the site.